Published in Clin Mol Pathol on October 01, 1995
Age related decrease of NOR activity in bone marrow metaphase chromosomes from healthy individuals. Mol Pathol (1998) 0.86
Nucleoli and AgNORs in Hodgkin's disease. Mol Pathol (1997) 0.79
Interphase ribosomal RNA cistron silver staining in refractory anaemias with and without excess blasts. Mol Pathol (1997) 0.75
Controlled silver-staining of nucleolus organizer regions with a protective colloidal developer: a 1-step method. Experientia (1980) 13.12
Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level. Histochem J (1986) 5.31
Nucleolar organizer regions in lymphomas. J Pathol (1987) 4.46
Quantity of nucleolar silver-stained proteins is related to proliferating activity in cancer cells. Lab Invest (1990) 1.64
Argyrophilic proteins of the nucleolar organizer region in acute leukemias and its relation to the S-phase fraction of leukemic cells. Acta Haematol (1992) 1.46
Nucleolar organiser regions. Curr Top Pathol (1990) 1.18
Argyrophilic nucleolar organiser region (AgNOR) staining in normal bone marrow cells. J Clin Pathol (1990) 1.11
Pattern of nucleolar organizer regions in human leukemic cells. Anal Cell Pathol (1993) 1.06
Interphase nucleolar organizer regions in cancer cells. Int Rev Exp Pathol (1991) 1.03
Nucleolar organizer region activity in human chromosomes and interphase nuclei of normal, leukemic, and tumor cells as evaluated by silver staining. Int Rev Cytol (1990) 0.93
Assessment of nucleolar organizer regions by automatic image analysis in breast cancer: correlation with DNA content, proliferation rate, receptor status and histopathological grading. J Cancer Res Clin Oncol (1990) 0.88
Argyrophilic nucleolar organizer region counts in multiple myeloma: a histopathological study on bone marrow trephine biopsies. Virchows Arch A Pathol Anat Histopathol (1992) 0.85
[Morpho-functional characteristics of normal and pathological human megakaryocytes studied by selective silver staining of cell nucleoli]. Gematol Transfuziol (1990) 0.84
Nucleolar organizer regions in normal hematopoiesis: relationship to cellular proliferation and maturation. Nouv Rev Fr Hematol (1991) 0.83
The activity of nucleolar organizer regions of human bone marrow cells studied with silver staining. I. Chronic myelocytic leukemia. Cancer Genet Cytogenet (1985) 0.83
AgNORs and myeloma prognosis. Leuk Lymphoma (1994) 0.81
Cytokinetic studies in chronic myeloid leukaemia: evidence for early presence of abnormal myeloblasts. Scand J Haematol (1972) 0.81
Argyrophilic nucleolar organizer region counts and prognosis in multiple myeloma. Br J Haematol (1992) 0.80
Nucleolar organizer regions in acute and chronic leukaemias. Acta Histochem (1992) 0.80
Kinetics of bone marrow cell production in human acute and chronic myeloid leukemias. Leuk Res (1980) 0.80
The activity of nucleolar organizer regions of human bone marrow cells studied with silver staining. II. Acute leukemia. Cancer Genet Cytogenet (1987) 0.79
Megakaryocyte polyploidy and maturation in chronic granulocytic leukemia. Acta Haematol (1988) 0.78
Differences in the composition and in the efficiency of red cell production of normal and CML erythroid progenitor populations are highlighted by response to human c-kit ligand. Leuk Res (1993) 0.78
Regulation of bone marrow myeloblast proliferation in chronic myeloid leukemia. Cancer Res (1976) 0.77
[Functional and structural changes in cells of the erythroid series and in thrombocytes in patients with leukemia]. Probl Gematol Pereliv Krovi (1975) 0.77
Autoradiographic and cytophotometric studies on granulocyte precursors in chronic myeloid leukaemia. Haematologica (1974) 0.77
Granulopoiesis and cell kinetics inchronic myeloid leukaemia. Cell Tissue Kinet (1974) 0.77
Nucleolar organizer regions of megakaryocytes in chronic myeloproliferative disorders. Virchows Arch A Pathol Anat Histopathol (1992) 0.77
Difference in uptake of tritiated thymidine by myelocytes from bone marrow and spleen in chronic myeloid leukaemia. Scand J Haematol (1973) 0.77
[Ultrastructural picture and nucleolus organizer activity of leukemic cells in children with acute lymphoblastic leukemia of the "general" type]. Gematol Transfuziol (1990) 0.77
A hypothetical model to explain the 'termination' of chronic myeloid leukemia into blastic crisis. Med Hypotheses (1991) 0.77
Biochemical abnormality of DNA synthesis of erythroblasts in acute and chronic myeloid leukemia. Blood (1973) 0.77
[Ag-negative phenomenon of nucleolar organizers of bone marrow and blood cells in children with acute lymphoblastic leukemia]. Eksp Onkol (1990) 0.77
Cell biology of CML--a model linking the chronic and terminal phases. Leuk Lymphoma (1993) 0.77
Erythropoiesis in CML--immunomorphometric quantification, PCNA-reactivity, and influence on survival. Hematol Pathol (1993) 0.77
Normal and leukaemic granulopoiesis. Haematologica (1981) 0.76
[Morpho-functional characteristics of normal and pathological human megakaryocytes studied by selective silver staining of cell nucleoli]. Gematol Transfuziol (1990) 0.84
Combined surgical and immunotherapeutic treatment of patients with fourth stage colon cancer. Hybridoma (1999) 0.76
Interphase ribosomal RNA cistron silver staining in refractory anaemias with and without excess blasts. Mol Pathol (1997) 0.75
[The use of interferon-alfa (reaferon) in patients with chronic myeloleukemia]. Ter Arkh (1996) 0.75
[Possibilities of transfusion therapy in surgical practice]. Vestn Khir Im I I Grek (2014) 0.75
[Activity of nucleolar organizers in megakaryocytes from patients with leukemia]. Gematol Transfuziol (1995) 0.75
[Megakaryocytopoiesis]. Gematol Transfuziol (1996) 0.75
[Prognostic significance of the activity of nucleolar organizer regions in megakaryocytes from patients with acute lymphoblastic leukemia]. Gematol Transfuziol (1996) 0.75
[Prognostic significance of immunoglobulin variable region gene mutations in B-CLL patients treated with combination therapy fludarabine plus cyclophosphamide]. Ter Arkh (2007) 0.75
[Liposomes in experimental virology]. Vopr Virusol (1990) 0.75
[Allelic distribution of the CYP1A1 in lung cancer patients, middle-aged tissue donors and in elderly people without cancer]. Vopr Onkol (2004) 0.75